e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Functional insights into COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of n acetylcystein on proteinas-inhibitory system with chronic bronchitis
O. Pavlenko, T. Pertseva, O. Lykholat (Dnepropetrovsk, Ukraine)
Source:
Annual Congress 2009 - Functional insights into COPD
Session:
Functional insights into COPD
Session type:
Thematic Poster Session
Number:
3817
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Pavlenko, T. Pertseva, O. Lykholat (Dnepropetrovsk, Ukraine). Effects of n acetylcystein on proteinas-inhibitory system with chronic bronchitis. Eur Respir J 2009; 34: Suppl. 53, 3817
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of N-acetylcystein on proteinas-inhibitory system in smokers with chronic obstructive bronchitis (COB)
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003
Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Source: Eur Respir Rev 2015; 24: 451-461
Year: 2015
Rheoplasty in chronic bronchitis
Source: Virtual Congress 2021 – Interventional pulmonology
Year: 2021
Mechanisms of persistence of
Streptococcus pneumoniae
following treatment of acute exacerbation of chronic bronchitis
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Acute bronchitis: aetiology and treatment
Source: Eur Respir Monogr 2013; 60: 1-17
Year: 2013
Mucoactive therapy in COPD
Source: Eur Respir Rev 2009; 19: 134-140
Year: 2010
Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Bacterial extract (OM-85) preventive effect in chronic bronchitis complicated with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 578s
Year: 2005
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Efficacy and cardiovascular safety of long-term bronchodilator therapy with theophylline in patients with chronic obstructive bronchitis (COB)
Source: Eur Respir J 2003; 22: Suppl. 45, 52s
Year: 2003
Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Molecular epidemiology of acute exacerbations of chronic bronchitis (AECB)
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002
Treatment of chronic cough with morphine
Source: Eur Respir J 2006; 28: Suppl. 50, 437s
Year: 2006
Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 138s
Year: 2001
Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept